Cargando…
Contemporary Management of Recurrent Nodal Disease in Differentiated Thyroid Carcinoma
Differentiated thyroid carcinoma (DTC) comprises over 90% of thyroid tumors and includes papillary and follicular carcinomas. Patients with DTC have an excellent prognosis, with a 10-year survival rate of over 90%. However, the risk of recurrent tumor ranges between 5% and 30% within 10 years of the...
Autores principales: | Na’ara, Shorook, Amit, Moran, Fridman, Eran, Gil, Ziv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rambam Health Care Campus
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737512/ https://www.ncbi.nlm.nih.gov/pubmed/26886954 http://dx.doi.org/10.5041/RMMJ.10233 |
Ejemplares similares
-
What is the Minimal Surgery for Papillary Thyroid Carcinoma?
por: Fridman, Eran, et al.
Publicado: (2016) -
External Beam Radiation in Differentiated Thyroid Carcinoma
por: Billan, Salem, et al.
Publicado: (2016) -
Risk Stratification in Differentiated Thyroid Cancer: An Ongoing Process
por: Omry-Orbach, Gal
Publicado: (2016) -
Genetic Testing in Differentiated Thyroid Carcinoma: Indications and Clinical Implications
por: Zolotov, Sagit
Publicado: (2016) -
A Risk-adapted Approach to Follow-up in Differentiated Thyroid Cancer
por: Tarasova, Valentina D., et al.
Publicado: (2016)